PCR / NGS
QUASAR-BRCA1/2
The testing kit is designed to detect germline and somatic mutations in the BRCA1, BRCA2 genes by NGS-sequencing and is recommended for determining predisposition to developing hereditary forms of breast cancer, ovarian cancer in healthy women, and when examining patients diagnosed with breast cancer and ovarian cancer in order to determination of effective treatment tactics.
PCR
HRR-SCREENING
The kit is designed to detect 16 germline mutations in the HRR genes and is used in screening for predisposition to breast, ovarian, prostate, pancreatic, and stomach cancer.
PCR
BRCA1,2-DIAGNOSTICS
The gene expression kit is designed to detect 16 germline mutations in the BRCA1 and BRCA2 genes and is used in the diagnosis of hereditary forms of breast, ovarian, pancreatic, and stomach cancer in order to determine an effective treatment strategy.
PCR
BRCA1,2-TISSUE
The gene expression kit is designed to detect 16 somatic mutations in the BRCA1 and BRCA2 genes and is used in the diagnosis of hereditary forms of breast, ovarian, pancreatic, and stomach cancer. The test allows predicting the course of the disease and determining an effective treatment strategy with both targeted medication and various chemotherapy programs.
PCR
TEST-BRAF-TISSUE
The testing kit is used when examining patients diagnosed with the metastatic melanoma stage III-IV in order to determine if they have indications for targeted therapy.
PCR
TEST-EGFR-PLASMA
The reagent kit is used in the examination of patients diagnosed with non-small cell lung cancer (NSCLC) to determine indications for targeted therapy with EGFR tyrosine kinase inhibitors and monitor response to them.
Designed by